WeVote
Log In

Bill

Bill

HB 5592

Ivermectin over the counter

2026 Regular Session

HB 5592 would allow over-the-counter ivermectin sales in West Virginia, removing prescription requirements and medical oversight for the anti-parasitic medication.

0
WeVote Research Nonpartisan
Bill Summary · HB 5592

Legislative bill overview

HB 5592 would allow ivermectin, an anti-parasitic medication, to be purchased over-the-counter without a prescription in West Virginia. Currently, ivermectin is a prescription-only medication regulated by the FDA for specific approved uses in humans (treating certain parasitic infections) and animals.

Why is this important

This bill addresses medication accessibility and cost for those seeking ivermectin, while raising significant public health concerns given widespread off-label use of the drug during the COVID-19 pandemic without clinical evidence of efficacy. The policy outcome would substantially affect how West Virginia regulates pharmaceutical access compared to federal standards.

Potential points of contention

  • Medical safety and misuse: Ivermectin taken without medical supervision can cause serious side effects, drug interactions, and overdose risk. Removing prescriber oversight eliminates professional assessment of appropriate dosing and patient suitability.
  • Unproven COVID-19 and other off-label uses: The bill may facilitate use for conditions lacking FDA approval and clinical evidence, particularly given recent public demand driven by misinformation campaigns.
  • Federal regulatory conflict: West Virginia cannot override federal FDA approval classifications; implementation would create legal ambiguity and likely face federal enforcement challenges.
  • Public health messaging: OTC availability could be perceived as endorsement, undermining trust in evidence-based treatment guidelines during future health crises.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.